Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population

2016-07-01
Kahraman, Deniz Cansen
Kahraman, Tamer
Atalay, Rengül
Citation Formats
D. C. Kahraman, T. Kahraman, and R. Atalay, “Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population,” 2016, vol. 61, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/69607.